P
Peter A. Lay
Researcher at University of Sydney
Publications - 316
Citations - 11216
Peter A. Lay is an academic researcher from University of Sydney. The author has contributed to research in topics: Chromium & Osmium. The author has an hindex of 52, co-authored 306 publications receiving 10372 citations. Previous affiliations of Peter A. Lay include The Heart Research Institute & University of California, Riverside.
Papers
More filters
Journal ArticleDOI
The Decamethylferrocenium/Decamethylferrocene Redox Couple: A Superior Redox Standard to the Ferrocenium/Ferrocene Redox Couple for Studying Solvent Effects on the Thermodynamics of Electron Transfer
Indra Noviandri,Kylie N. Brown,Douglas S. Fleming,Peter T. Gulyas,Peter A. Lay,A.F. Masters,Leonidas Phillips +6 more
TL;DR: In this article, the solvent dependence of the formal redox potentials of the ferrocenium/ferrocene (Fc+/0) and 1,2,3,4,5-pentamethylferrocenium (Me5Fc+,/0), compared with the decamethy-lferricenium/decamethyelferrocenes (Me10Fc-,/
Journal ArticleDOI
Recent developments in ruthenium anticancer drugs.
TL;DR: A diversity of modes of action of Ru anticancer drugs is likely to enhance their anticancer activities and to reduce the potential for them to develop tumour resistance.
Journal ArticleDOI
Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized
Jane E. Weder,Carolyn T. Dillon,Trevor W. Hambley,Brendan J. Kennedy,Peter A. Lay,J. Ray Biffin,Hubert Leonardus Regtop,Neal M. Davies +7 more
TL;DR: If the potential opportunities of the Cu-NSAIDs are to be completely realized, a mechanistic understanding and delineation of their in vivo and in vitro pharmacological activity is fundamental, along with further characterization of their pharmacokinetic/pharmacodynamic disposition.
Journal ArticleDOI
Mechanistic studies of relevance to the biological activities of chromium
Aviva Levina,Peter A. Lay +1 more
TL;DR: A review of the existing knowledge on the mechanisms of biologically relevant redox reactions of Cr(VI/V/IV/III) complexes is presented in this article, with 142 references.
Journal ArticleDOI
Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes
Stephanie M.Y. Kong,Brian K.K. Chan,Jin-Sung Park,Kathryn J. Hill,Jade B. Aitken,Jade B. Aitken,Jade B. Aitken,Louise Cottle,Hovik Farghaian,Adam R. Cole,Peter A. Lay,Carolyn M. Sue,Antony A. Cooper,Antony A. Cooper +13 more
TL;DR: It is proposed ATP13A2's modulation of zinc levels in MVBs can regulate the biogenesis of exosomes capable of containing α-Synuclein, the first PD-associated gene involved in exosome biogenesis and indicates a potential neuroprotective role ofExosomes in PD.